Navigation Links
A New Anti-Cancer Drug Keeps Resistance Out

An experimental drug named Dasatinib, developed by Bristol-Myers Squibb company offers a valuable treatment against the signs and symptoms of chronic myeloid leukemia// patients than the usual drug named Gleevec.

Patients, who are resistant to Gleevec drug can now be treated with dasatinib, which seems to regulate intolerance and complications of chronic myeloid leukemic patients - studies published in NEJM finds.

In the phase I clinical trials dasatinib overcome Gleevec resistance in about 68 of 84 patients studied - study leader, HHMI investigator Charles L. Sawyers, and colleagues at UCLA's Jonsson Comprehensive Cancer Center, reported.

People in all 3 stages of the disease such as chronic phase, the accelerated phase, and blast crisis respond to the new drug quite possibly, Sawyers says.

Sawyers said, ‘Drug-related mutations are better understood by the application of experimental drug, dasatinib to subjects and even individual patient’s mutation type were easily studied by scientists at Bristol-Myers Squibb’.

‘How drug target mutation take place and whether molecular explanation of drugs has any role to play in it’ all studied by the scientists, showing improvements in structural biology studies.

Due to being as a ‘sloppier inhibitor’ meaning - does not hold its target to such tight structural constraints, dasatinib differs from the drug Gleevec.

Sawyers added dasatinib proves its value to overcome kinase resistance in managing cancer patients and also keep rooting in other fields of medicine like molecular oncology and structural biology.
'"/>




Page: 1

Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. FDA Approves Anti-Cancer Cell Drug - Zevalin
3. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
4. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
5. Antidepressant Drug Found To Have Anti-Cancer Effects
6. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Exercise Has An Anti-Cancer Effect
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... 2017 , ... With the Grand Opening Event planned for February 3, 2017, ... teams and the general public. Built in five months by Centerpoint, the 60,000 square ... basketball or pickleball courts. The space is also suitable for indoor soccer and football ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:1/16/2017)... ... January 16, 2017 , ... In 1985, ... and high-level training standards to an international multidisciplinary group of healthcare treatment providers ... a way to further its mission at the grassroots level, iaedp launched MemberSHARE, ...
(Date:1/15/2017)... ... 2017 , ... In this role, Courtney will be responsible for developing new ... allergy friendly mark. This certification program was created by ASL and the nonprofit Asthma ... more suitable for the 60+ million people living in the U.S. with asthma and ...
(Date:1/15/2017)... ... 15, 2017 , ... San Francisco Magazine recently queried area ... for 2017. Almost 1,000 nominations were submitted and a little over 500 physicians ... announced the magazine’s January 2017 issue . , Under the category of ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... When synthetic Fentanyl arrived on the streets in 2015, dealers ... free samples, inviting would-be customers to test a newly-created batch. ... The rapidly-growing demand for the ... morphine, has racked up a staggering death toll across ... recorded fentanyl sales reveals that they have sold nearly 400 ...
(Date:1/16/2017)... PUNE, India , January 16, 2017 ... titled, "Vital Signs Monitoring Devices Market by Type and End ... the global vital signs monitoring devices market size was worth ... million by 2022, growing at a CAGR of 5.8% from ... the leading regional market in global vital signs monitoring devices ...
(Date:1/16/2017)... January 16, 2017 ... Product Type (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl, Carboxymethyl ... Beverages, Surface Coatings & Paints), Region - ... the market was valued at USD 4.51 ... reach USD 6.41 Billion by 2021, at ...
Breaking Medicine Technology: